Cargando…
The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
Globally, pancreatic ductal adenocarcinoma remains among the most aggressive forms of neoplastic diseases, having a dismal prognostic outcome. Recent findings elucidated that epithelial–mesenchymal transition (EMT) can play an important role in pancreatic tumorigenic processes, as it contributes to...
Autores principales: | Gulla, Aiste, Andriusaityte, Urte, Zdanys, Gabrielius Tomas, Babonaite, Elena, Strupas, Kestutis, Kelly, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032206/ https://www.ncbi.nlm.nih.gov/pubmed/35454306 http://dx.doi.org/10.3390/medicina58040467 |
Ejemplares similares
-
Tethered Lipid Membranes as a Nanoscale Arrangement towards Non-Invasive Analysis of Acute Pancreatitis
por: Budvytyte, Rima, et al.
Publicado: (2021) -
Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
por: Park, Ji‐Hye, et al.
Publicado: (2019) -
Role of epithelial-mesenchymal transition in chemoresistance in pancreatic ductal adenocarcinoma
por: Hu, Xiu, et al.
Publicado: (2021) -
Interdisciplinary Approach of Establishing PDAC Resectability: Biochemical, Radiological and NAT Regimen Prognostic Factors—Literature Review
por: Gulla, Aiste, et al.
Publicado: (2022) -
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)